Press releases
- Aethlon Medical Announces Pricing of $4.7 Million Public Offering
- Aethlon Medical Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles From Cancer Patient Plasma
- Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devices
Key statistics
On Thursday, Aethlon Medical Inc (EJU0:FRA) closed at 0.328, 0.00% above its 52-week low of 0.328, set on May 17, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.328 |
---|---|
High | 0.328 |
Low | 0.328 |
Bid | -- |
Offer | -- |
Previous close | 0.362 |
Average volume | 1.60k |
---|---|
Shares outstanding | 2.62m |
Free float | 2.45m |
P/E (TTM) | -- |
Market cap | 1.05m USD |
EPS (TTM) | -5.03 USD |
Data delayed at least 15 minutes, as of May 16 2024.
More ▼